Skip to main content
SpringerLink
Log in

Acute Myeloid Leukemia in Children

Standard of Care and Future Perspectives

  • Book
  • Aug 2024
  • Latest edition

Overview

Editors:
  1. Daisuke Tomizawa

    1. Div Leuk Lymphoma, Childrens Cancer Ctr, National Center for Child Health & Development, Tokyo, Japan

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Edward Anders Kolb

    1. Division of Hematology/Oncology, Nemours Children's Health, Wilmington, Wilmington, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Dirk Reinhardt

    1. Department of Pediatrics III, University of Duisburg-Essen, Essen, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Covers key aspects of pediatric AML including basic science diagnosis and treatment
  • Presents up-to-date information on treatment for pediatric AML based on recently completed clinical trials
  • Provides readers with novel information on the biology of pediatric AML

Part of the book series: Pediatric Oncology (PEDIATRICO)

Buy print copy

Keywords

  • Acute Promyelocytic Leukemia
  • Myelodysplastic Syndrome
  • Myeloid Proliferations
  • Hematopoietic Stem Cell Transplantation
  • Minimal Residual Disease
  • Measurable Residual Disease
  • De Novo AML
  • Extramedullary AML
  • Stem Cell Transplantation in AML
  • Late effects in Pediatric AML Survivors
  • Infection Management in Pediatric AML
  • Caridiotoxicity in Pediatric AML

About this book

This book provides up-to-date information on key topics and issues in Pediatric Acute Myeloid Leukemia (AML), including the epidemiology, biology, diagnosis and treatment of particular forms of the disease, supportive care, and survivorship. The entire spectrum of clinical management on pediatric AML is covered with the aim of equipping readers with the latest knowledge relevant to clinical practice and research, based on enormous efforts made by cooperative clinical trial groups and consortia worldwide. Each chapter is written by internationally renowned authorities who have been selected for their expertise in the subjects discussed. This book will serve pediatric hematologists/oncologists, fellows, and residents both as a comprehensive source of information and as a quick reference. The book will also be of interest to pediatricians and general practitioners.

Editors and Affiliations

  • Div Leuk Lymphoma, Childrens Cancer Ctr, National Center for Child Health & Development, Tokyo, Japan

    Daisuke Tomizawa

  • Division of Hematology/Oncology, Nemours Children's Health, Wilmington, Wilmington, USA

    Edward Anders Kolb

  • Department of Pediatrics III, University of Duisburg-Essen, Essen, Germany

    Dirk Reinhardt

About the editors

Dr. Daisuke Tomizawa is a pediatric hematologist/oncologist and Head of the Division of Leukemia and Lymphoma at the Children's Cancer Center, National Center for Child Health and Development in Tokyo, Japan. He served as Vice Chair of the Japan Children's Cancer Group (JCCG) acute myeloid leukemia (AML) disease committee from 2010-2019 and Chair from 2019-2023, which is responsible for the design and conduct of clinical trials and linked translational research studies that enroll approximately 80% of Japanese children and adolescents with this disease. He is also involved in various international research projects in collaboration with North American, Western European, and Asian investigators in this field.

Dr. Edward Anders Kolb is a pediatric hematologist/oncologist, and most recently served as Chief of the Division of Hematology and Oncology of Nemours Children’s Health, Wilmington, Delaware, and Professor of Pediatrics, Sidney Kimmel Medical College at Thomas Jefferson University. Dr. Kolb also served as Chair of the Children’s Oncology Group (COG) Myeloid Disease Committee from 2013-2023, which is the largest pediatric AML research consortium in the world. He is a strong advocate for international collaboration and leads the development of several international clinical trials. Since 2023, Dr. Kolb was appointed as President and Chief Executive Officer, The Leukemia & Lymphoma Society (LLS) in its mission to cure blood cancers and improve the quality of life for patients and their families.

Prof. Dr. Dirk Reinhardt is a pediatric hematologist/oncologist and Head of Pediatrics III, Pediatric Hematology, Oncology and Stem Cell Therapy at the University Children's Hospital Essen, Germany. He is chairman of the AML-BFM study group, which conducts clinical trials as well as basic and translational research on pediatric AML. As Managing Director of the German Society for Pediatric Oncology and Hematology (GPOH gGmbH) and Director of the EuPAL Foundation, he promotes international projects in drug and therapy development for the treatment of cancer and leukemia in children.

 

 

Bibliographic Information

  • Book Title: Acute Myeloid Leukemia in Children

  • Book Subtitle: Standard of Care and Future Perspectives

  • Editors: Daisuke Tomizawa, Edward Anders Kolb, Dirk Reinhardt

  • Series Title: Pediatric Oncology

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2024

  • Hardcover ISBN: 978-3-031-63365-2Due: 07 September 2024

  • Softcover ISBN: 978-3-031-63368-3Due: 07 September 2024

  • eBook ISBN: 978-3-031-63366-9Due: 07 September 2024

  • Series ISSN: 1613-5318

  • Series E-ISSN: 2191-0812

  • Edition Number: 1

  • Number of Illustrations: 45 b/w illustrations, 25 illustrations in colour

Publish with us

Policies and ethics

Back to top

Search

Navigation